Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

Novoheart licenses Harvard technology to develop Next-Gen human heart-in-a-jar

biospectrumasiaDecember 18, 2019

Tag: Novoheart , Next-Gen , human heart-in-a-jar

PharmaSources Customer Service